This article provides a detailed guide for researchers, scientists, and drug development professionals on the regulatory pathway for manufacturing cell therapies in the European Union.
This article provides a comprehensive analysis of current protocols for differentiating human induced pluripotent stem cells (iPSCs) into cardiomyocytes (iPSC-CMs).
This article provides a detailed, state-of-the-art overview of the autologous induced pluripotent stem cell (iPSC) therapy pipeline, tailored for researchers, scientists, and drug development professionals.
This article explores the integrated application of CRISPR-Cas9 gene editing and induced pluripotent stem cell (iPSC) technologies for disease correction and therapeutic development.
This article provides a comprehensive overview of mRNA-based technology for cell fate reprogramming, a transformative approach in regenerative medicine and drug development.
This article explores the transformative role of 3D bioprinting in fabricating complex, biomimetic tissue architectures for advanced biomedical applications.
This article provides a comprehensive analysis of the paracrine hypothesis in stem cell-based regenerative medicine.
This article provides a comprehensive overview of Integrative and Regenerative Pharmacology (IRP), an emerging interdisciplinary field that merges pharmacological sciences, systems biology, and regenerative medicine to develop transformative, curative therapies.
Human induced pluripotent stem cells (hiPSCs) have revolutionized biomedical research by enabling the generation of patient-specific cellular models for a wide range of diseases.
This article provides a comprehensive analysis of the role of mesenchymal stem cell (MSC)-derived exosomes in wound healing, tailored for researchers, scientists, and drug development professionals.